Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8999331 Immunobinders directed against sclerostin

Patent 8999331 was granted and assigned to AbbVie Inc. on April, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 6 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11999783 Method of treating autoimmune disease with antibodies against IL-33
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+294 characters)
Article

Patent abstract

Proteins that bind sclerostin or sclerostin and TNF are described along with there use in composition and methods for treating, preventing, and diagnosing sclerostin related diseases and for detecting sclerostin or sclerostin and TNF in cells, tissues, samples, and compositions.

Edits on 27 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Alexander Ivanov0
Alyssa Brito0
Chung-Ming Hsieh0
Emma Fung0
Jacqueline Bixby0
John Memmott0
Lorenzo Benatuil0
Sahana Bose0
Wendy Waegell0
Yuliya Kutskova0
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=089993310
Edits on 23 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08999331 Immunobinders directed against sclerostin US Patent 8999331 Immunobinders directed against sclerostin

Infobox
Patent Number
089993310
Patent Number
89993310
Edits on 31 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 31 Mar, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
AbbVie Inc.
AbbVie Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
089993310
Date of Patent
April 7, 2015
0
Patent Application Number
136596470
Date Filed
October 24, 2012
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=089993310
Patent Primary Examiner
‌
Elizabeth C. Kemmerer
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08999331
Edits on 29 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 29 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08999331 Immunobinders directed against sclerostin

Infobox
Is a
Patent
Patent
Current assignee
AbbVie Inc.
AbbVie Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08999331
Date of patent
April 7, 2015
Patent application number
13659647
Date Filed
October 24, 2012
Patent primary examiner
‌
Elizabeth C. Kemmerer

Find more entities like US Patent 8999331 Immunobinders directed against sclerostin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.